# p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

> **NCT04104945** · NA · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 32 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of the Oropharynx

## Interventions

- **RADIATION:** De-intensified chemoradiotherapy

## Key facts

- **NCT ID:** NCT04104945
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-12
- **Primary completion:** 2028-10-21
- **Final completion:** 2028-10-21
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04104945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04104945, "p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04104945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*